Preventing sexual transmission of hsv and hiv: The challenge for active and passive immunization of mucosal surfaces

Biotechnology and Genetic Engineering Reviews

Volumn 19, Issue 1, 2002, Pages 121-138

  Zeitlin, Larry ^a   Palmer, Carrie ^a   Whaley, Kevin J ^a  

^a Epicyte Pharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCOSAL SURFACE; PASSIVE IMMUNIZATION;

IMMUNOGLOBULIN A;

ACTIVE IMMUNIZATION; ADOPTIVE IMMUNOTHERAPY; ANTIBODY RESPONSE; CELLULAR IMMUNITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION PREVENTION; NONHUMAN; PASSIVE IMMUNIZATION; REVIEW; SEXUAL TRANSMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VAGINA MUCOSA; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS;

EID: 0036917065     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.1080/02648725.2002.10648026     Document Type: Article

References (94)

1. Anderson, D. and Yunis, E. (1983). "Trojan horse" leukocytes in AIDS. New England Journal of Medicine 309, 984-985.
2. Asha. (1998). Sexually transmitted diseases in America: how many cases and at what cost? Research Triangle Park, NC: American Social Health Association.
3. Baua, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., Cavacini, L. A., Posner, M. R., Katinger, H., Stiegler, G., Bernacky, B. J., Rlzvl, T. A., Schmidt, R., Hill, L. R., Keeling, M. E., Lu, Y., Wright, J. E., Chou, T. C. and Ruprecht, R. M. (2000). Human neutralizing monoclonal antibodies of the IgM subtype protect against mucosal simian-human immunodeficiency virus infection. Nature Medicine 6, 200-206.
4. Binder, G. K. and Griffin, D. E. (2001). INTERFERON-GAMMA-MEDIATED SITE-SPECIFIC CLEARANCE OF ALPHAVIRUS FROM CNS NEURONS. Science 293, 303-306.
5. Bomsel, Ml, Heyman, M., Hocini, H., Lagaye, S., Belec, L., Dupont, C. and Desgranges, C. (1998). Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dlgA or IgM. Immunity 9, 277-287.
6. Brandtzaeg, P., Baekkevold, E. S., Farstad, I. N., Jahnsen, F. L., Johansen, F. -E., Nilsen, E. M. and Yamanak, T. (1999). Regional specialization in the mucosa! immune system: what happens in the microcompartments? Immunology Today 20, 141-151.
7. Briggs, K., Zeitlin, L., Wang, F., Chen, L., Fitchen, J., Glynn, J., Lee, V., Zhang, S. and Whaley, K. (2000). An anti-HSV antibody produced in transgenic rice plants prevents vaginal HSV-2 infection in micc. AIDS 15, S19.
8. Buge, S. L., Richardson, E., Alipanah, S., Markham, P., Cheng, S., Kalyan, N., Miller, C. J., Lubeck, M., Udem, S., Eldridge, J. and Robert-Guroff, M. (1997). AN ADENOVIRUS-SIMIAN IMMUNODEFICIENCY VIRUS ENV VACCINE ELICITS HUMORAL, CELLULAR, AND MUCOSAl IMMUNE RESPONSES IN RHESUS MACAQUES AND DECREASES VIRAL BURDEN FOLLOWING VAGINAL CHALLENGE. Journal of Virology 71, 8531-8541.
9. Buge, S. L., Murty, L., Arora, K., Kalyanaraman, V. S., Markham, P. D., Richardson, E. S., Aldrich, K., Patterson, L. J., Miller, C. J., Cheng, S. M. and Robert-Guroff, M. (1999). Factors associated with siow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp]20 boosting regimen and challenged vaginally with SIVmac251. Journal of Virology 73, 7430-7440.
10. Burkhard, M. J., Obert, L. A., O'Neil, L. L., Diehl, L.J.L. and Hoover, E. A. (1997). Mucosal transmission of celi-associated and cell-free feline immunodeficiency virus, AIDS Research and Hitman Retroviruses 13, 347-355.
11. Burton, D. R. (1997). A vaccine for HIV type 1: the antibody perspective. National Academy of Sciences of the United States of America. Proceedings 94, 10018-10023.
12. Cohen, M., Weber, R., Mardh, P. -A. and anderson, D. (1999). Genitourinary mucosal defenses. In: Sexually transmitted diseases. Eds. K, Holmes, P. Sparling, P. -A. Mardh, S. Lemon, W. Stamm, P. Piot and J. Wasserheit, pp 173-190. New York: McGraw-Hill.
13. Cone, R. (1999). Mucus. In: Mucosal immunology. Eds, P. Ogra, M. Lamm, J. Bienenstock, J. Mestecky, W. Strober and J. McGhee, pp 43-64. New York: Academic Press.
14. Cone, R. A. and Whaley, K. J. (1994). Monoclonal antibodies for reproductive health: Part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies. American Journal of Reproductive Immunology 32, 114-131.
15. Corey, L., Langenberg, A. G., Ashley, R., Sekulovich, R. E., Izu, A. E., Douglas, J. M. Jr., Hands Field, H. H., Warren, T., Marr, L., Tyring, S., Dicarlo, R., Adimora, A. A., Leone, P., Dekker, C. L., Burke, R. L., Leong, W. P. and Straus, S. E. (1999), Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 282, 331-340.
16. Cranage, M. P., Baskerville, A., Ashworth, L. A., Dennis, M., Cook, N., Sharpe, S., Farrar, G., Rose, J., Kitchin, P. A. and Greenaway, P. J. (1992). Intrarectal challenge of macaques vaccinated with formaiin-inacti vated simian immunodeficiency virus Lancet 339, 273-274.
17. Crowley-Nowick, P. A., Bell, M. C., Brockwell, R., Edwards, R. P., Chen, S., Partridge, E. E. and Mestecky, J. (1997). Rectal immunization for induction of specific antibody in the genital tract of women. Journal of Clinical Immunology 17, 370-379.
18. D'Souza, P., Livnat, D., Bradac, J., Bridges, S. and The Aids Clinical Trials Group Antibody Selection Working Group. (1997). Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. Journal of Infectious Diseases 175, 1056-1062.
19. Eis-Hobinger, A., Schmidt, D. and Schneweis, K. (1993). Anti-glycoprotein B monoclonal antibody protects mice against genital herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. Journal of General Virology 74, 379-385.
20. Eng, T. and Butler, W. (Eds.) (1997). The hidden epidemic. Washington, DC: National Academy Press.
21. Franklin, R. D. and Kutteh, W. H. (1999). Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. Journal of Reproductive Immunology 42, 93-106.
22. Friedman, H. M. (2000). Immunological strategies for herpes vaccination. JAMA 283, 746.
23. Gauduin, M. -C., Safrit, J., Weir, R., Fung, M. and Koup, R. (1995). Pre- and postexposure protection against human immunodeficiency virus type 1 infection metiated by a monoclonal antibody. Journal of Infectious Diseases 171, 1203-1209.
24. Gauduin, M. -C., Parren, P. W., Weir, R., Barbas, C. F., Burton, D. R. and Koup, R. A. (1997). Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1, Nature Medicine 3, 1389-1393.
25. Greenhead, P., Hayes, P., Waits, P. S., Lanig, K. G., Griffin, G. E. and Shattock, R. J. (2000). Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginai virucides. Journal of Virology 74, 5577-5586.
26. Grjffin, D., Levine, B., Tyor, W., Ubol, S. and Despres, P. (1997), The role of antibody in recovery from alphavirus encephalitis. Immunological Reviews 159, 155-161.
27. Hioe, C. E., Hildreth, J. E. and Zolla-Pazner, S. (1999). ENHANCED HIV TYPE 1 NEUTRALIZATION BY HUMAN ANTI-GLYCOPROTEIN 120 MONOCLONAL ANTIBODIES IN THE PRESENCE OF MONOCLONAL ANTIBODIES TO LYMPHOCYTE FUNCTION-ASSOCIATED MOLECULE 1. AIDS Research and Human Retroviruses 15, 523-531.
28. Hofmann-Lehmann, R., Rasmussen, R. A., Vlasak, J., Smith, B. A., Baba, T. W., Liska, V., Montefiori, D. C., Mcclure, H. M., anderson, D. C., Bernacky, B. J., Rizvi, T. A., Schmidt, R., Hill, L. R., Keeling, M. E., Katinger, H., Stiegler, G., Posner, M. R., Cavacini, L. A., Chou, T. C. and Ruprecht, R. M. (2001). PASSIVE IMMUNIZATION AGAINST ORAL AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission? Journal of Medical Primatology 30, 190-196.
29. Hook, E., Pate, M., Hedges, S., Russell, M. and Mestecky, J. (1999). Mucosal immunology of sexually transmitted diseases. In: Mucosal immunology. Eds, P. Ogra, M. Lamm, J. Bienenstock, J. Mestecky, W. Strober and J. McGhee, pp 1463-1481. New York: Academic Press.
30. Houdebine, L. M. (2000). Transgenic animal bioreactors. Transgenic Research 9, 305-320.
31. Hu, J., Gardner, M. B, and Miller, C. J. (2000). Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intra vaginal inoculation and infects intraepitheiial dendritic ceils. Journal of Virology 74, 6087-6095.
32. Ibata, B., Parr, E. L., King, N. J. and Parr, M. B. (1997). Migration of foreign lymphocytes from the mouse vagina into the cervicovaginal mucosa and to the iliac lymph nodes. Biology of Reproduction 56, 537-543.
33. Johnson, R. P., Lifson, J. D., Czajak, S. C., Cole, K. S., Manson, K. H., Glickman, R., Yang, J., Montefiori, D. C., Montelaro, R., Wyand, M. S. and Desrosiers, R. C. (1999). HIGHLY ATTENUATED VACCINE STRAINS OF SIMIAN IMMUNODEFICIENCY VIRUS PROTECT AGAINST VAGINAL CHALLENGE: INVERSE RELATIONSHIP OF DEGREE OF PROTECTION WITH LEVEL OF ATTENUATION. Journal of Virology 73, 4952-4961.
34. Khanna, K., Whaley, K., Zeftlin, L., Moench, T., Mehrazar, K., Cone, R., Liao, Z., Hildreth, J., Hoen, T., Shultz, L. and Markham, R. (2002). Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane modifying agent. Journal of Clinical Investigation 109, 205-211.
35. Koelle, D. M. and Wald, A. (2000). Herpes simplex virus: the importance of asymptomatic shedding. Journal of Antimicrobial Chemotherapy 45, Suppl. T3, 1-8.
36. Kong, Q., Richter, L., Yang, Y. F., Arntzen, C. J., Mason, H. S. and Thanavala, Y. (2001). Oral immunization with hepatitis B surface antigen expressed in transgenic plants. National Academy of Sciences of the United States of America. Proceedings 11, 11.
37. Kozlowski, P. A., Cu-Uvin, S., Neutra, M. R. and Flanigan, T. P. (1997). Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infection and Immunity 65, 1387-1394.
38. Kozlowski, P. A., Cu-Uvin, S., Neutra, M. R. and Flanigan, T. P. (1999). Mucosal vaccination strategies for women. Journal of Infectious Diseases 179, Suppl. 3, S493-S498.
39. Kuklin, N. A., Daheshia, M., Chun, S. and Rouse, B. T. (1998). Role of mucosal immunity in herpes simplex virus infection. Journal of Immunology 160, 5998-6003.
40. Kuntz, R. M. and Saltzman, W. M. (1997). Polymeric controlled delivery for immunization. Trends in Biotechnology 15, 364-369.
41. Kutteh, W. (1999). Mucosal immunity in the human female reproductive tract. In: Mucosal immunology. Eds, P. Ogra, M. Lamm, J. Bienenstock, J. Mestecky, W, Strober and J. McGhee, pp 1423-1434. New York: Academic Press.
42. Lehner, T., Wang, Y., Cranage, M., Bergmeier, L. A., Mitchell, E., Tao, L., Hall, G., Dennis, M., Cook, N., Brookes, R., Klavinskis, L., Jones, I., Doyle, C. and Ward, R. (1996). PROTECTIVE MUCOSAL IMMUNITY ELICITED BY TARGETED ILIAC LYMPH NODE IMMUNIZATION WITH A SUBUNIT SIV ENVELOPE AND CORE VACCINE IN MACAQUES. Nature Medicine 2, 767-775.
43. Ma, J. K., Hikmat, B. Y., Wycoff, K., Vine, N. D., Chargelegue, D., Yu, L., Hein, M. B. and Lehner, T. (1998). Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans [see comments]. Nature Medicine 4, 601-606.
44. Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulugan, M. J., Yamsi-Ichikov, G. V., Cl-Ien, D. and Eldridge, J. H. (1993). Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260, 1323-1327.
45. Mascola, J. R. (1999). Herpes simplex virus vaccines - why don't antibodies protect? JAMA 282, 379-380.
46. Mascola, J. R. and Nabel, G J. (2001). Vaccines for the prevention of HI V-1 disease. Current Opinion in Immunology 13, 489-494.
47. Mascola, J. R., Frankel, S. S. and Broliden, K. (2000a). HIV-1 entry at the mucosal surface: role of antibodies in protection. Aids 14, S167-174.
48. Mascola, J. R., Stiegler, G., Vancott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L. and Lewis, M. G. (2000b). Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nature Medicine 6, 207-210.
49. Mathleson, B. (2000). HIV vaccines: milestones and insights. In: Sexually transmitted diseases. Eds, L. Stanberry and D. Bernstein, pp 421-457. Cambridge: Academic Press.
50. Mazzoli, S., Trabattoni, D., Lo Caputo, S., Piconi, S., Ble, C., Meacci, F., Ruzzante, S., Salvi, A., Sempuci, F., Longhi, R., Fusi, M.L., Tofam, N., Biasin, M., Villa, M. L., Mazzotta, F. and Cleric!, M. (1997). HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nature Medicine 3, 1250-1257.
51. Mcdermott, M., Goldsmith, C., Rosenthal, K. and Brais, L. (1989). T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. Journal of Infectious Diseases 159, 460-466.
52. Miller, C. J. (1998). Localization of simian immunodeficiency virus-intected cells in the genital tract of male and female rhesus macaques. Journal of Reproductive Immunology 41, 331-339.
53. Miller, C. J., Mcchesney, M. B., Lu, X., Dailey, P. J., Chutkowski, C., Lu, D., Brosio, P., Roberts, B. and Lu, Y. (1997). RHESUS MACAQUES PREVIOUSLY INFECTED WITH SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS ARE PROTECTED FROM VAGINAL CHALLENGE WITH PATHOGENIC SI VMAC239. Journal of Virology 71, 1911-1921.
54. Milligan, G. N., Bernstein, D. L and Bourne, N. (1998). T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. Journal of Immunology 160, 6093-6100.
55. Moench, T. R., Whaley, K. J., Mandrell, T. D., Bishop, B. D., Witt, C. J. and Cone, R. A. (1993). The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. Aids 7, 797-802.
56. Moench, T., Blumenthal, P., Cone, R. and Whaley, K. (2000). Antibodies may provide prolonged microbicidal activity due to their long residence time in the vagina. In: Microbicides 2000, Abstract B15. Alexandria, VA.
57. Moore, J. P. (2002). Novel entry inhibitors. Microbiocides 2002, May 12-15. Abstract A-292. Antwerp, Belgium.
58. Moore, J. P. and Burton, D. R, (1999). HIV-1 neutralizing antibodies: how full is the bottle? Nature Medicine 5, 142-144
59. Norvell, M. K., Benrubi, G. I. and Thompson, R. J. (1984). Investigation of microtrauma after sexual intercourse. Journal of Reproductive Medicine 29, 269-271.
60. O'Hara, B., Franti, M., Olson, W., Nagashima, K., Burton, D., Maddon, P. and Poignard, P. (2001). Potent in vivo suppression of HIV-1 replication with single-dose PRO 140, a novel inhibitor of CCR5-mediated viral entry. 14th International Conference on Antiviral Research, Seattle, WA.
61. Parr, E. L. and Parr, M. B. (1997). Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. Journal of Virology 71, 8109-8115.
62. Parr, M. and Parr, E. (1999). Female genital tract immunity in animal models. In: Mucosal immunology. Eds, P. Ogra, M. Lamm, J. Bienensiock, J. Mcstccky, W. Strober and J. McGhee, pp 1395-1409. New York: Academic Press.
63. Parr, M. B. and Parr, E. L. (2000). Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice. Immunology 101, 126-131.
64. Parren, P. W., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J., Cheng-Mayer, C., Moore, J. P. and Burton, D. R. (2001). Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. Journal of Virology 75, 8340-8347.
65. Pertel, P. and Spear, P. (1999). Biology of herpes viruses. In: Sexually transmitted diseases. Eds, K. Holmes, P. Sparling, P. -A. Mardh, S. Lemon, W. Stamm, P. Piot and J. Wasserheit, pp 269-283. New York: McGraw-Hill.
66. Poignard, P., Sabbe, R., Plcciho, G. R., Wang, M., Gulizia, R. J., Katinger, H., Parren, P. W., Mosier, D. E. and Burton, D. R. (1999). Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 10, 431-438.
67. Pollock, D. P., Kutzko, J. P., Blrck-Wllson, E., Williams, J. L., Echelard, Y. and Meade, H. M. (1999). Transgenic milk as a method for the production of recombinant antibodies. Journal of Immunological Methods 231, 147-157.
68. Population Council. (2000). The caseformicrobicides: a global priority. Population Council and International Family Health.
69. Putkonen, P., Thorstensson, R., Ghavamzadeh, L., Albert, J., Hild, K., Biberfeld, G. and Norrby, E. (1991). Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature 352, 436-438.
70. Radomsky, M. L., Whaley, K. J., Cone, R. A. and Saltzman, W. M. (1992). Controlled vaginal delivery of antibodies in the mouse. Biology of Reproduction 47, 133-140.
71. Reitter, J. N. and Desrosiers, R. C. (1998). IDENTIFICATION OF REPLICATION-COMPETENT STRAINS OF SIMIAN IMMUNODEFICIENCY VIRUS LACKING MULTIPLE ATTACHMENT SITES FOR N-LINKED CARBOHYDRATES IN VARIABLE REGIONS 1 AND 2 OF THE SURFACE ENVELOPE PROTEIN. Journal of Virology 72, 5399-5407.
72. Ross, M., Reith, E. and Romrell, L. (1989). Histology: a text and atlas, 2nd/Ed. Baltimore: Williams and Wilkins.
73. Sherwood, J., Zeitun, L., Whaley, K., Cone, R. and Saltzman, W. (1996a). Controlled release of antibodies for long-term topical passive iinmunoprotection of female mice against genital herpes. Nature Biotechnology 14, 468-471.
74. Sherwood, J. K., Zeitlin, L., Chen, X., Whaley, K. J., Cone, R. A. and Saltzman, W. M. (1996b). Residence half-life of IgG administered topically to the mouse vagina. Biology of Reproduction 54, 264-269.
75. Shibata, R., Igarashi, T., Haigwood, N., Buckler-Wiiite, A., Ogert, R., Ross, W., Willey, R., Cho, M. W. and Martin, M. A. (1999). Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-i/SIV chimeric virus infections of macaque monkeys. Nature Medicine 5, 204-210.
76. Sodora, D. L., Gettie, A., Miller, C. J. and Marx, P. A. (1998). Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and Cell-Associated Viral Stocks. AIDS Research and Human Retroviruses 14. Suppl. 1. S119-S123.
77. Spruance, S. L. and The Smitiikline Beeciiam Herpes Vaccine Efficacy Study Group (2000). Genderspecific Efficacy Ofaprophylacticsbas4-Adjuvantgd, Subunit Vaccine Against Genital Herpes Disease (Ghd): Results Of Two Clinical Efficacy Trials (Abstract). 40Th Interscience Conference On Antimicrobial Agents and Chemotherapy. Toronto, Canada, 2000.
78. Stanberry, L. (2000). Genital and perinatal herpes simplex virus infections: prophylactic vaccines. In: Sexually transmitted diseases. Eds, L. Stanberry and D. Bernstein, pp 187-216. San Diego: Academic Press.
79. Stanberry, L. R., Cunningham, A. L., Mindel, A., Scott, L. L., Spruance, S. L., Aoki, F. Y. and Lacey, C. J. (2000). Prospects for control of herpes simplex virus disease through immunization. Clinical Infectious Diseases 30. 549-566.
80. Terhune, S. S., Coleman, K. T., Sekulovich, R., Burke, R. L. and Spear, P. G. (1998). Limited variability of glycoprotein gene sequences and neutralizing targets in herpes simplex virus type 2 isolates and stability on passage in cell culture. Journal of Infectious Diseases 178, 8-15.
81. Trkola, A., Khtas, T. J., Nagashima, K. A., Zhao, L., Cilliers, T., Morris, L., Moore, J. P., Maddon, P. J. and Olson, W. C. (2001). Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140. Journal of Virology 75, 579-588.
82. Van Rompay, K. K., Berardi, C. J., Dillard-Telm, S., Tarara, R. P., Canfield, D. R., Val Verde, C. R., Montefiori, D. C., Cole, K. S., Montelaro, R. C., Miller, C. J. and Marthas, M. L. (1998). PASSIVE IMMUNIZATION OF NEWBORN RHESUS MACAQUES PREVENTS ORAL SIMIAN IMMUNODEFICIENCY VIRUS INFECTION. Journal of Infectious Diseases 177, 1247-1259
83. Wald, A. (1998). Herpes. Transmission and viral shedding. Dermatologia Clinica 16, 795-797, 14.
84. Wang, C. Y., Sawyer, L. S., Murthy, K. K., Fang, X., Walfield, A. M., Ye, J., Wang, J. J., Chen, P. D., Li, M. L., Salas, M. T., Shen, M., Gauduin, M. C., Boyle, R. W., Koup, R. A., Montefiori, D. C., Mascola, J. R., Koff, W. C. and Hanson, C. V. (1999). POSTEXPOSURE IMMUNOPROPHYLAXIS OF PRIMARY ISOLATES BY AN ANTIBODY TO HIV RECEPTOR COMPLEX. National Academy of Sciences of the United States of America. Proceedings 96, 10367-10372.
85. Whaley, K. and Zeitlin, L. (2001). Antibodies as mucosal protectants [French], Annales de I'lnstitut Pasteur/actuaiites 7, 83-100.
86. Whaley, K. J., Zeitlin, L., Barratt, R. A., Hoen, T. E. and Cone, R. A, (1994). Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. Journal of Infectious Diseases 169, 647-649.
87. Wyatt, T. L., Whaley, K. J., Cone, R. A. and Saltzman, W. M. (1998). Antigen-releasing polymer rings and microspheres stimulate mucosal immunity in the vagina. Journal of Controlled Release 50, 93-102.
88. Yeaman, G. R., White, H. D., Howell, A., Prabhala, R. and Wira, C. R. (1998). The mucosal immune system in the human femate reproductive tract: potential insights into the heterosexual transmission ot HIV. AIDS Research and Human Retroviruses 14, Suppl. 1, S57-S62.
89. Zeitlin, L., Whaley, K. J., Sanna, P. P., Moench, T. R., Bastidas, R., De Logu, A., Williamson, R. A., Burton, D. R. and Cone, R. A. (1996). Topically applied human recombinant monoclonal IgGl antibody and its Fab and F(ab')2 fragments protect mice from vagina! transmission of HSV-2. Virology 225, 213-215.
90. Zeitlin, L., Whaley, K. J., Hegarty, T. A., Moench, T. R. and Cone, R. A. (1997). Tests of vaginal microbicides in the mouse genital herpes model. Contraception 56, 329-335.
91. Zeitlin, L., Castle, P., Whaley, K., Moench, T. and Cone, R. (1998a). Comparison of an anti-HS V-2 monoclonal IgG and its IgA switch variant for topica! immunoprotection of the mouse vagina. Journal of Reproductive Immunology 40, 93-101.
92. Zeitlin, L., Olmsted, S., Moench, T., Co, M., Martinell, B., Paradkar, V., Russel, D., Queen, C., Cone, R, and Whaley, K. (1998b). A HUMANIZED MONOCLONAL ANTIBODY PRODUCED IN TRANSGENIC PLANTS FOR IMMUNOPROTECTION OF THE VAGINA AGAINST GENITAL HERPES. Nature Biotechnology 16, 1361-1364
93. Zeitlin, L., Cone, R. A. and Whaley, K. J. (1999). USING MONOCLONAL ANTIBODIES TO PREVENT MUCOSAL TRANSMISSION OF EPIDEMIC INFECTIOUS DISEASES. Emerging Infectious Diseases 5, 54-64.
94. Zeitlin, L., Cone, R. A., Moench, T. R. and Whaley, K. J. (2000). Preventing infectious disease with passive immunization. Microbes and Infection 2, 701-708.